2Mesยท

Medpace Holdings reports FY2024

Medpace Holdings ($MEDP (+3,59%) ) reports Q4 2024 earnings:

Q4 2024:

Sales: 536.6M vs. 535.0M expected (+0.3%) ๐ŸŸก

EBITDA: 133.5M vs. 115.2M expected (+15.89%) ๐Ÿš€

EBIT: 125.4M vs. 107.9M expected (+16.22%) ๐Ÿš€

Net Income: 117.0M vs. 96.1M expected (+21.75%) ๐Ÿš€


FY2024:

Sales: 2109.0M vs. 2107.0M expected (+0.09%) ๐ŸŸก

EBITDA: 480.2M vs. 460.4M expected (+4.3%) ๐ŸŸข

EBIT: 446.9M vs. 431.3M expected (+3.62%) ๐ŸŸข

Net Income: 404.4M vs. 383.7M expected (+5.39%) ๐ŸŸข

CapEx: 36.5M vs. 42.0M expected (-13.1%)

FCF: 572.3M vs. 472.1M expected (+21.22%) ๐Ÿš€


Outlook for FY2025:

Sales: 2160.0M vs. 2238.0M expected (-3.49%) ๐Ÿ”ด

EBITDA: 479.0M vs. 482.1M expected (-0.64%) ๐ŸŸก

Net Income: 390.0M vs. 403.4M expected (-3.32%) ๐Ÿ”ด


Backlog / Sales sinkt das erste Mal unter 1 (auf 0.99). Aber der Abschwung verlangsamt sich deutlich. Ausblick liegt unter Erwartungen

5
2 Commenti

immagine del profilo
do you see a buy or wait and see?
โ€ขโ€ข
Mostra la risposta
Partecipa alla conversazione